These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23367508)

  • 21. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
    Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
    Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) model of depression in mice.
    Farooq RK; Tanti A; Ainouche S; Roger S; Belzung C; Camus V
    Psychoneuroendocrinology; 2018 Nov; 97():120-130. PubMed ID: 30015007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications.
    Dandekar MP; Fenoy AJ; Carvalho AF; Soares JC; Quevedo J
    Mol Psychiatry; 2018 May; 23(5):1094-1112. PubMed ID: 29483673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective Effect of Irbesartan an Angiotensin (AT1) Receptor Antagonist in Unpredictable Chronic Mild Stress Induced Depression in Mice.
    Ayyub M; Najmi AK; Akhtar M
    Drug Res (Stuttg); 2017 Jan; 67(1):59-64. PubMed ID: 27756096
    [No Abstract]   [Full Text] [Related]  

  • 25. Magnolol treatment reversed the glial pathology in an unpredictable chronic mild stress-induced rat model of depression.
    Li LF; Yang J; Ma SP; Qu R
    Eur J Pharmacol; 2013 Jul; 711(1-3):42-9. PubMed ID: 23632393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
    Farley S; Dumas S; El Mestikawy S; Giros B
    Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression.
    Alonso R; Griebel G; Pavone G; Stemmelin J; Le Fur G; Soubrié P
    Mol Psychiatry; 2004 Mar; 9(3):278-86, 224. PubMed ID: 14699428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SN003, a CRF
    Wróbel A; Doboszewska U; Rechberger E; Wlaź P; Rechberger T
    Eur J Pharmacol; 2017 Oct; 812():216-224. PubMed ID: 28705713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging.
    Isingrini E; Belzung C; d'Audiffret A; Camus V
    Am J Geriatr Psychiatry; 2011 Apr; 19(4):335-46. PubMed ID: 21427642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The application of vagus nerve stimulation and deep brain stimulation in depression.
    Mohr P; Rodriguez M; Slavíčková A; Hanka J
    Neuropsychobiology; 2011; 64(3):170-81. PubMed ID: 21811087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression: A Randomized Clinical Trial.
    Bergfeld IO; Mantione M; Hoogendoorn ML; Ruhé HG; Notten P; van Laarhoven J; Visser I; Figee M; de Kwaasteniet BP; Horst F; Schene AH; van den Munckhof P; Beute G; Schuurman R; Denys D
    JAMA Psychiatry; 2016 May; 73(5):456-64. PubMed ID: 27049915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression.
    Nollet M; Gaillard P; Minier F; Tanti A; Belzung C; Leman S
    Neuropharmacology; 2011; 61(1-2):336-46. PubMed ID: 21530551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression.
    Merkl A; Schneider GH; Schönecker T; Aust S; Kühl KP; Kupsch A; Kühn AA; Bajbouj M
    Exp Neurol; 2013 Nov; 249():160-8. PubMed ID: 24012926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic unpredictable mild stress-induced depressive-like behavior and dysregulation of brain levels of biogenic amines in Drosophila melanogaster.
    Araujo SM; Poetini MR; Bortolotto VC; de Freitas Couto S; Pinheiro FC; Meichtry LB; de Almeida FP; Santos Musachio EA; de Paula MT; Prigol M
    Behav Brain Res; 2018 Oct; 351():104-113. PubMed ID: 29803654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep Brain Stimulation Modulates Gamma Oscillations and Theta-Gamma Coupling in Treatment Resistant Depression.
    Sun Y; Giacobbe P; Tang CW; Barr MS; Rajji T; Kennedy SH; Fitzgerald PB; Lozano AM; Wong W; Daskalakis ZJ
    Brain Stimul; 2015; 8(6):1033-42. PubMed ID: 26195320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Models of Affective Illness: Chronic Mild Stress in the Rat.
    Papp M; Willner P
    Curr Protoc; 2023 Mar; 3(3):e712. PubMed ID: 36892313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?
    Nielsen DM
    Life Sci; 2006 Jan; 78(9):909-19. PubMed ID: 16122764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased dopamine receptor expression and anti-depressant response following deep brain stimulation of the medial forebrain bundle.
    Dandekar MP; Luse D; Hoffmann C; Cotton P; Peery T; Ruiz C; Hussey C; Giridharan VV; Soares JC; Quevedo J; Fenoy AJ
    J Affect Disord; 2017 Aug; 217():80-88. PubMed ID: 28395208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.